胆囊原发性透明细胞癌1例报告

刘永硕; 夏俊杰; 沈兴艳; 王艳龙; 孙象军

doi:10.3969/j.issn.1001-5256.2023.04.023

胆囊原发性透明细胞癌1例报告

DOI: 10.3969/j.issn.1001-5256.2023.04.023

1.
潍坊医学院，山东潍坊 261000
2.
滨州医学院，山东烟台 264000
3.
广州中医药大学研究生院，广州 510000
4.
临沂市人民医院肝胆外科，山东临沂 276000

基金项目:

山东省重点研发计划项目 (2018GSF118191);

山东省医药卫生科技发展计划项目 (2017WS321)

伦理学声明：本例报告已获得患者知情同意。

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：刘永硕负责课题设计，资料分析，撰写论文；夏俊杰、王艳龙参与收集数据，修改论文；沈兴艳参与修改论文；孙象军负责拟定写作思路，指导撰写文章并最后定稿。

详细信息

通信作者:
孙象军，sunxjun2004@sina.com (ORCID: 0000-0002-5958-9556)

计量
- 文章访问数: 226
- HTML全文浏览量: 55
- PDF下载量: 41
- 被引次数: 0
出版历程
- 收稿日期: 2022-09-06
- 录用日期: 2022-10-06
- 出版日期: 2023-04-20

Primary clear cell carcinoma of the gallbladder: A case report

1.
Weifang Medical College, Weifang, Shandong 261000, China
2.
Binzhou Medical College, Yantai, Shandong 264000, China
3.
Guangdong University of Traditional Chinese Medicine, Guangzhou 510000, China
4.
Department of Hepatobiliary Surgery, Linyi People's Hospital, Linyi, Shandong 276000, China

Research funding:

Shandong Province Key R&D Program Project (2018GSF118191);

Shandong Provincial Medicine and Health Science and Technology Development Plan Project (2017WS321)

More Information

Corresponding author: SUN Xiangjun, sunxjun2004@sina.com (ORCID: 0000-0002-5958-9556)

摘要

- 胆囊肿瘤 /
- 腺癌, 透明细胞 /
- 诊断, 鉴别
- Gallbladder Neoplasms /
- Adenocarcinoma, Clear Cell /
- Diagnosis, Differential

HTML全文

图 1 患者CT检查结果

注：a，动脉期；b，静脉期；c，延迟期。增强CT检查提示胆囊体积大，壁增厚，胆囊底部见不规则软组织肿块影，其内密度欠均，呈渐进性明显强化，局部与相邻肝脏分界欠清。

Figure 1. CT examination results

下载: 全尺寸图片幻灯片

图 2 术后病理结果(HE染色，×100)

Figure 2. Postoperative pathology (HE staining, ×100)

下载: 全尺寸图片幻灯片

参考文献(11)

[1]	Branch of Biliary Surgery, Chinese Surgical Society; Chinese Committee of Biliary Surgeons. Guideline for the diagnosis and treatment of gallbladder carcinoma (2019 edition)[J]. Chin J Surg, 2020, 58(4): 243-251. DOI: 10.3760/cma.j.cn112139-20200106-00014. 中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科专业委员会. 胆囊癌诊断和治疗指南(2019版)[J]. 中华外科杂志, 2020, 58(4): 243-251. DOI: 10.3760/cma.j.cn112139-20200106-00014.
[2]	MAHARAJ R, CAVE C, SARRAN K, et al. A case report of the clear cell variant of gallbladder carcinoma[J]. Int J Surg Case Rep, 2017, 32: 36-39. DOI: 10.1016/j.ijscr.2017.01.020.
[3]	YI XM, HE SG, MO ZQ. Expression of CCR3 in renal clear cell carcinoma and its effect on invasion and metastasis of renal clear cell carcinoma cells[J]. J Clin Exp Med, 2021, 20(6): 598-602. DOI: 10.3969/j.issn.1671-4695.2021.06.011. 易小明, 何树光, 莫祚群. CCR3在肾透明细胞癌中的表达及对肾透明细胞癌细胞侵袭、转移能力的影响[J]. 临床和实验医学杂志, 2021, 20(6): 598-602. DOI: 10.3969/j.issn.1671-4695.2021.06.011.
[4]	SU J, WANG G, FENG SW. Expression and clinical significance of miR-4313 and TBX15 in clear cell renal cell carcinoma[J]. China Med Herald, 2021, 18(10): 19-22, cover 3. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202110006.htm 苏计, 王刚, 冯世伟. 透明细胞肾细胞癌组织中miR-4313、TBX15的表达及临床意义[J]. 中国医药导报, 2021, 18(10): 19-22, 封3. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202110006.htm
[5]	LIU TT, FU X, WANG YM, et al. Clinicopathologic observation of rare gallbladder malignant clear cell tumors[J]. Mod Oncol, 2019, 27(9): 1566-1570. DOI: 10.3969/j.issn.1672-4992.2019.09.024. 刘坦坦, 付欣, 王映梅, 等. 胆囊罕见恶性透明细胞肿瘤的临床病理观察[J]. 现代肿瘤医学, 2019, 27(9): 1566-1570. DOI: 10.3969/j.issn.1672-4992.2019.09.024.
[6]	COSTA NEVES M, NEOFYTOU K, GIAKOUSTIDIS A, et al. Two cases of gallbladder metastasis from renal cell carcinoma and review of literature[J]. World J Surg Oncol, 2016, 14: 87. DOI: 10.1186/s12957-016-0843-3.
[7]	ZHANG C, ZHANG W, MU D, et al. A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature[J]. Onco Targets Ther, 2016, 9: 5797-5802. DOI: 10.2147/OTT.S103291.
[8]	ZHENG Z, CHEN XF, CHENG Y, et al. Gallbladder metastasis from renal clear cell carcinoma: a case report[J]. Chin J Urol, 2021, 42(7): 542-543. DOI: 10.3760/cma.j.cn112330-20200407-00273. 郑重, 陈晓峰, 程跃, 等. 肾透明细胞癌胆囊转移一例报告[J]. 中华泌尿外科杂志, 2021, 42(7): 542-543. DOI: 10.3760/cma.j.cn112330-20200407-00273.
[9]	YAO XJ, CHEN XY, XU JQ, et al. Gallbladder metastasis of clear cell renal cell carcinoma: A case report and literature review[J]. Chin J Hepatobiliary Surg, 2019, 25(2): 127-128. DOI: 10.3760/cma.j.issn.1007-8118.2019.02.012. 姚秀娟, 陈祥义, 许建秋, 等. 肾透明细胞癌胆囊转移一例并文献复习[J]. 中华肝胆外科杂志, 2019, 25(2): 127-128. DOI: 10.3760/cma.j.issn.1007-8118.2019.02.012.
[10]	ZHANG W, YU WJ, XIA Y, et al. Expression of carbonic anhydrase Ⅸ, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors[J]. Chin J Pathol, 2013, 42(7): 442-445. DOI: 10.3760/cma.j.issn.0529-5807.2013.07.003. 张伟, 于文娟, 夏岩, 等. 碳酸酐酶Ⅸ、PAX2和PAX8在肾上皮性肿瘤中的表达及临床病理意义[J]. 中华病理学杂志, 2013, 42(7): 442-445. DOI: 10.3760/cma.j.issn.0529-5807.2013.07.003.
[11]	TIAN W, DING HH, YU Y, et al. The clinical significance of Ki-67 in judging the postoperative prognosis of patients with unexpected gallbladder cancer[J]. J Guzhou Med Univ, 2020, 45(10): 1208-1213. DOI: 10.19367/j.cnki.2096-8388.2020.10.016. 田雾, 丁海华, 于洋, 等. Ki-67对意外胆囊癌术后患者预后判断的价值[J]. 贵州医科大学学报, 2020, 45(10): 1208-1213. DOI: 10.19367/j.cnki.2096-8388.2020.10.016.